# BankUnited, Inc.: financial statements, quarterly

BKU · NYSE · CIK 1504008 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bku.md) · [Financials](/companies/bku/financials.md) · [Filings](/companies/bku/filings.md) · [Insiders](/companies/bku/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bku/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [5.2](/filings/0001504008-24-000030.md) | [5.2 d](/filings/0001504008-26-000011.md) | [5.3](/filings/0001504008-25-000012.md) | [4.9](/filings/0001504008-25-000022.md) | [5.0](/filings/0001504008-25-000046.md) | [5.0 d](/filings/0001504008-26-000011.md) | [5.2](/filings/0001504008-26-000043.md) | [5.3](/filings/0001504008-26-000079.md) | [5.4](/filings/0001504008-25-000046.md) | [5.8 d](/filings/0001504008-26-000011.md) | [6.2](/filings/0001504008-26-000043.md) | [6.3](/filings/0001504008-26-000079.md) |
| Interest expense | $m | [256](/filings/0001504008-24-000030.md) | [266](/filings/0001504008-24-000006.md) | [267](/filings/0001504008-24-000013.md) | [257](/filings/0001504008-24-000022.md) | [258](/filings/0001504008-24-000030.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [15.4](/filings/0001504008-25-000005.md) | [3.4](/filings/0001504008-25-000005.md) | [19.2](/filings/0001504008-26-000011.md) | [19.2](/filings/0001504008-26-000011.md) | [21.7](/filings/0001504008-26-000011.md) | [23.7](/filings/0001504008-26-000011.md) | [21.6](/filings/0001504008-26-000043.md) | [25.1](/filings/0001504008-26-000079.md) | [26.1](/filings/0001504008-26-000011.md) | [20.6](/filings/0001504008-26-000011.md) | [19.9](/filings/0001504008-26-000043.md) | [23.7](/filings/0001504008-26-000079.md) |
| Net income | $m | [47.0](/filings/0001504008-25-000005.md) | [20.8](/filings/0001504008-25-000005.md) | [48.0](/filings/0001504008-26-000011.md) | [53.7](/filings/0001504008-26-000011.md) | [61.5](/filings/0001504008-26-000011.md) | [69.3](/filings/0001504008-26-000011.md) | [58.5](/filings/0001504008-26-000043.md) | [68.8](/filings/0001504008-26-000079.md) | [71.9](/filings/0001504008-26-000011.md) | [69.3](/filings/0001504008-26-000011.md) | [61.9](/filings/0001504008-26-000043.md) | [70.7](/filings/0001504008-26-000079.md) |
| Diluted EPS | $ per share | [0.63](/filings/0001504008-25-000005.md) | [0.27](/filings/0001504008-25-000005.md) | [0.64](/filings/0001504008-26-000011.md) | [0.72](/filings/0001504008-26-000011.md) | [0.81](/filings/0001504008-26-000011.md) | [0.91](/filings/0001504008-26-000011.md) | [0.78](/filings/0001504008-26-000043.md) | [0.91](/filings/0001504008-26-000079.md) | [0.95](/filings/0001504008-26-000011.md) | [0.90](/filings/0001504008-26-000011.md) | [0.83](/filings/0001504008-26-000043.md) | [0.97](/filings/0001504008-26-000079.md) |
| Basic EPS | $ per share | [0.63](/filings/0001504008-25-000005.md) | [0.27](/filings/0001504008-25-000005.md) | [0.64](/filings/0001504008-26-000011.md) | [0.72](/filings/0001504008-26-000011.md) | [0.82](/filings/0001504008-26-000011.md) | [0.92](/filings/0001504008-26-000011.md) | [0.78](/filings/0001504008-26-000043.md) | [0.91](/filings/0001504008-26-000079.md) | [0.96](/filings/0001504008-26-000011.md) | [0.91](/filings/0001504008-26-000011.md) | [0.83](/filings/0001504008-26-000043.md) | [0.97](/filings/0001504008-26-000079.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.4](/filings/0001504008-23-000034.md) | [0.6](/filings/0001504008-25-000005.md) | [0.4](/filings/0001504008-24-000013.md) | [0.4](/filings/0001504008-24-000022.md) | [0.9](/filings/0001504008-24-000030.md) | [0.5](/filings/0001504008-26-000011.md) | [0.4](/filings/0001504008-25-000012.md) | [0.8](/filings/0001504008-25-000022.md) | [0.6](/filings/0001504008-25-000046.md) | [0.2](/filings/0001504008-26-000079.md) | [0.4](/filings/0001504008-26-000043.md) | [0.4](/filings/0001504008-26-000079.md) |
| Total assets | $bn | [35.4](/filings/0001504008-23-000034.md) | [35.8](/filings/0001504008-25-000005.md) | [35.1](/filings/0001504008-24-000013.md) | [35.4](/filings/0001504008-24-000022.md) | [35.8](/filings/0001504008-24-000030.md) | [35.2](/filings/0001504008-26-000011.md) | [34.8](/filings/0001504008-25-000012.md) | [35.5](/filings/0001504008-25-000022.md) | [35.1](/filings/0001504008-25-000046.md) | [35.0](/filings/0001504008-26-000079.md) | [35.4](/filings/0001504008-26-000043.md) | [34.9](/filings/0001504008-26-000079.md) |
| Total liabilities | $bn | [32.9](/filings/0001504008-23-000034.md) | [33.2](/filings/0001504008-25-000005.md) | [32.5](/filings/0001504008-24-000013.md) | [32.7](/filings/0001504008-24-000022.md) | [33.0](/filings/0001504008-24-000030.md) | [32.4](/filings/0001504008-26-000011.md) | [31.9](/filings/0001504008-25-000012.md) | [32.5](/filings/0001504008-25-000022.md) | [32.0](/filings/0001504008-25-000046.md) | [32.0](/filings/0001504008-26-000079.md) | [32.3](/filings/0001504008-26-000043.md) | [31.9](/filings/0001504008-26-000079.md) |
| Long-term debt | $bn | not reported | [0.7](/filings/0001504008-25-000005.md) | not reported | not reported | not reported | [0.7](/filings/0001504008-26-000011.md) | not reported | not reported | [0.3](/filings/0001504008-25-000046.md) | [0.3](/filings/0001504008-26-000011.md) | not reported | not reported |
| Short-term borrowings | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [2.5](/filings/0001504008-24-000030.md) | [2.6](/filings/0001504008-25-000046.md) | [2.6](/filings/0001504008-25-000022.md) | [2.7](/filings/0001504008-25-000046.md) | [2.8](/filings/0001504008-25-000046.md) | [2.8](/filings/0001504008-26-000079.md) | [2.9](/filings/0001504008-26-000079.md) | [3.0](/filings/0001504008-26-000079.md) | [3.0](/filings/0001504008-25-000046.md) | [3.1](/filings/0001504008-26-000079.md) | [3.0](/filings/0001504008-26-000079.md) | [3.0](/filings/0001504008-26-000079.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [170 d](/filings/0001504008-24-000030.md) | [63.8 d](/filings/0001504008-26-000011.md) | [66.5](/filings/0001504008-25-000012.md) | [136 d](/filings/0001504008-25-000022.md) | [46.1 d](/filings/0001504008-25-000046.md) | [186 d](/filings/0001504008-26-000011.md) | [16.4](/filings/0001504008-26-000043.md) | [118 d](/filings/0001504008-26-000079.md) | [99.7 d](/filings/0001504008-25-000046.md) | [125 d](/filings/0001504008-26-000011.md) | [18.3](/filings/0001504008-26-000043.md) | [129 d](/filings/0001504008-26-000079.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Dividends paid | $m | [20.1 d](/filings/0001504008-24-000030.md) | [20.1 d](/filings/0001504008-26-000011.md) | [20.7](/filings/0001504008-25-000012.md) | [21.5 d](/filings/0001504008-25-000022.md) | [21.6 d](/filings/0001504008-25-000046.md) | [21.6 d](/filings/0001504008-26-000011.md) | [22.2](/filings/0001504008-26-000043.md) | [23.2 d](/filings/0001504008-26-000079.md) | [23.3 d](/filings/0001504008-25-000046.md) | [23.3 d](/filings/0001504008-26-000011.md) | [24.1](/filings/0001504008-26-000043.md) | [24.3 d](/filings/0001504008-26-000079.md) |
| Share repurchases | $m | [0.0 d](/filings/0001504008-24-000030.md) | [0.0 d](/filings/0001504008-26-000011.md) | [0.0](/filings/0001504008-24-000013.md) | [0.0 d](/filings/0001504008-24-000022.md) | [0.0 d](/filings/0001504008-24-000030.md) | [0.0 d](/filings/0001504008-26-000011.md) | [0.0](/filings/0001504008-26-000043.md) | [0.0 d](/filings/0001504008-26-000079.md) | not reported | not reported | [60.0](/filings/0001504008-26-000043.md) | [50.6 d](/filings/0001504008-26-000079.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [77.1](/filings/0001504008-23-000034.md) | [74.0](/filings/0001504008-24-000013.md) | [73.4](/filings/0001504008-24-000022.md) | [73.8](/filings/0001504008-24-000030.md) | [73.6](/filings/0001504008-25-000012.md) | [74.0](/filings/0001504008-25-000022.md) | [74.5](/filings/0001504008-25-000046.md) | [74.4](/filings/0001504008-26-000043.md) | [74.6](/filings/0001504008-26-000079.md) | [74.8](/filings/0001504008-25-000046.md) | [73.9](/filings/0001504008-26-000043.md) | [71.8](/filings/0001504008-26-000079.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 71,232,249 at 2026-08-04, from the cover of the [10-Q filed 2026-08-06](/filings/0001504008-26-000079.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:41 ET. No prices; not investment advice.